221 related articles for article (PubMed ID: 343976)
41. Potassium-sparing diuretics: interaction with digoxin in elderly men.
Finnegan TP; Spence JD; Cape RD
J Am Geriatr Soc; 1984 Feb; 32(2):129-31. PubMed ID: 6363492
[TBL] [Abstract][Full Text] [Related]
42. [Effects of a potassium-sparing diuretic in cardiac edema and ascitic cirrhosis].
Schena FP; Vox E; Salvatore C
Clin Ter; 1977 Sep; 82(5):489-94. PubMed ID: 336259
[No Abstract] [Full Text] [Related]
43. Combination diuretic drug therapy.
Reubi FC
Cardiovasc Clin; 1971; 2(3):197-210. PubMed ID: 4950425
[No Abstract] [Full Text] [Related]
44. Use of diuretics in the treatment of cirrhotic ascites.
Boyer TD; Warnock DG
Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
[No Abstract] [Full Text] [Related]
45. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
[TBL] [Abstract][Full Text] [Related]
46. [Intractractable ascites in alcoholic cirrhosis: treatmemt by punctures and reinjections of ascitic fluid associated with diuretics].
Perrin D; Bredoux P; Arzul C; Bergerault P; Dedieu P; Miniconi P
Arch Fr Mal App Dig; 1974; 63(5):365-73. PubMed ID: 4463921
[No Abstract] [Full Text] [Related]
47. [Clinico-statistical observations on the use of triamterene in hepatic cirrhosis in the ascitic phase].
Cairella M; De Martiis M; Nasta G
Clin Ter; 1968 Aug; 46(3):198-202. PubMed ID: 5757655
[No Abstract] [Full Text] [Related]
48. [Diuretics in cirrhosis. Accidents. Indications].
Andrieu J; Lesueur G
Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378
[No Abstract] [Full Text] [Related]
49. [Properties and indications of potassium-sparing diuretics].
Rorive G; Krzesinski JM
Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
[No Abstract] [Full Text] [Related]
50. [Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis].
Marra N; Micheli E; Spagnolo G
Clin Ter; 1979 Jul; 90(2):143-63. PubMed ID: 527296
[No Abstract] [Full Text] [Related]
51. Use of bumetanide in the treatment of ascites due to liver disease.
Moult PJ; Lunzer MR; Trash DB; Sherlock S
Postgrad Med J; 1975; 51 Suppl 6():81-84. PubMed ID: 1105537
[No Abstract] [Full Text] [Related]
52. Spironolactone and frusemide in cirrhosis with ascites.
Sadikali F
Br J Clin Pract; 1973 Jun; 27(6):222-4. PubMed ID: 4582147
[No Abstract] [Full Text] [Related]
53. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
Heinrich F; Loew D; Dýcka J
Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
[TBL] [Abstract][Full Text] [Related]
54. [Triamterene in therapy of ascites in the cirrhotic].
Cairella M; Borrelli PL
Minerva Med; 1963 Oct; 54(81 Suppl):3027-8. PubMed ID: 5877335
[No Abstract] [Full Text] [Related]
55. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
Haris A; Radó J
Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
[TBL] [Abstract][Full Text] [Related]
56. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
Traina M; Vizzini GB
Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
[TBL] [Abstract][Full Text] [Related]
57. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
58. Cirrhosis complications: keeping them under control.
Minor SE; Eliacin I; Kashan S; Whisenant EB
J Fam Pract; 2015 Jun; 64(6):338-42. PubMed ID: 26172625
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].
Sanguigni D; Benvenuti C
Clin Ter; 1978 Oct; 87(1):69-74. PubMed ID: 737980
[No Abstract] [Full Text] [Related]
60. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
Onuigbo MA; Ozoh JO; Nusiem CA; Onyeagocha AC; Nwaneri O; Offodile AA; Ijoma CK
Cent Afr J Med; 1991 Aug; 37(8):244-7. PubMed ID: 1807797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
